Sporadic breast cancer in young women: Prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2

International Journal of Cancer

Volumn 98, Issue 2, 2002, Pages 205-209

  Johnson, Suzanne M ^a   Shaw, Jacqueline A ^a   Walker, Rosemary A ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

BRCA1; BRCA2; Breast carcinoma; Loss of heterozygosity; p53

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 17Q; DNA MODIFICATION; EARLY CANCER; FEMALE; GENE FREQUENCY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MARKER GENE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; FEMALE; GENE FREQUENCY; GENES, BRCA1; GENES, BRCA2; GENES, P53; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED;

EID: 0037051084     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10197     Document Type: Article

References (37)

1. Trends in breast cancer in younger women in contrast to older women
2. Histological grade of breast cancer in younger women
3. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients
4. Breast cancer outcome and predictors of outcome: Are there age differentials?
5. Breast carcinomas occurring in young women (< 35 years) are different
6. The relation between survival and age at diagnosis in breast cancer
7. Age as a prognostic factor in breast cancer
8. Age as prognostic factor in premenopausal breast carcinoma
9. Younger women with breast carcinoma have a poorer prognosis than older women
10. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
11. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases
12. Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma
13. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer
14. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: Pathological correlations
15. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer
16. Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: Association with poor survival
17. BRCA2 mutations in primary breast and ovarian cancers
18. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13
19. Consortium study on 1280 breast carcinomas: Allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters
20. Microsatellite instability in early sporadic breast cancer
21. Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas
22. Mutation of the TP53 gene and allelic imbalance at chromosome 17pl3 in ductal carcinoma in situ
23. A second-generation linkage map of the human genome
24. Dinucleotide repeat polymorphism in the human thyroid hormone receptor alpha gene (THRA) on chromosome 17
25. High-density genetic map of the BRCA1 region of chromosome 17q12-q21
26. The 1993-94 Genethon human genetic linkage map
27. Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas
28. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer
29. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer
30. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance
31. Frequency of breast cancer attributable to BRCA1 in a population based series of American women
32. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
33. Microsatellite instability in ductal carcinoma in situ of the breast
34. Association of BRCA1 with Rad51 in mitotic and meiotic cells
35. Molecular portraits of human breast turnouts
36. The human ROX gene: Genomic structure and mutation analysis in human breast tumors